Related Experiment Video

Updated: May 18, 2026

Analyzing Telomeric Protein-DNA Interactions Using Single-Molecule Magnetic Tweezers
11:21

Analyzing Telomeric Protein-DNA Interactions Using Single-Molecule Magnetic Tweezers

Published on: August 30, 2024

A small molecule inhibitor of Pot1 binding to telomeric DNA

Sarah E Altschuler1, Johnny E Croy, Deborah S Wuttke

  • 1Department of Chemistry and Biochemistry, University of Colorado, Boulder, Colorado 80309-0215, USA.

Biochemistry
|September 18, 2012
PubMed

Insights

Researchers identified Congo red as a specific inhibitor of Pot1/ssDNA binding, a key target for cancer drug development. This discovery offers a new strategy for disrupting telomere maintenance and combating cancer proliferation.

Area of Science:

  • Molecular biology
  • Biochemistry
  • Cancer research

Background:

  • Telomeres, the protective caps of chromosomes, are crucial for maintaining genomic stability.
  • Dysregulation of telomere maintenance is a hallmark of cancer, making telomeres a significant drug target.
  • Pot1 (protection of telomeres 1) regulates the single-stranded DNA (ssDNA) overhang at telomeres, and its inhibition impacts cell proliferation.

Purpose of the Study:

  • To develop a high-throughput screen for inhibitors of the Pot1/ssDNA interaction.
  • To identify compounds that specifically disrupt Pot1 binding to telomeric DNA.
  • To establish a novel therapeutic strategy for targeted telomere disruption in cancer.

Main Methods:

  • A high-throughput time-resolved fluorescence resonance energy transfer (TR-FRET) screen was employed.
  • The DNA-binding subdomain of *Schizosaccharomyces pombe* Pot1 (Pot1pN) was used for screening a library of approximately 20,000 compounds.
  • Isothermal titration calorimetry and NMR chemical shift analysis were used to characterize inhibitor binding.

Main Results:

  • A single potent inhibitor, Congo red (CR), was identified with sub-micromolar affinity.
  • CR was shown to competitively inhibit human Pot1 (hPOT1) binding to telomeric DNA.
  • CR specifically binds to the ssDNA-binding cleft of Pot1, and modifications to this site abolish CR binding.

Conclusions:

  • The identification of Congo red as a specific inhibitor of Pot1/ssDNA interaction is a significant advancement.
  • This finding validates Pot1/ssDNA binding as a druggable target for telomere disruption.
  • This research opens a new avenue for developing targeted cancer therapies by interfering with telomere maintenance.

More Related Videos

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Related Concept Videos

Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...